Tianda Pharmaceuticals Limited (HKG:0455)

Hong Kong · Delayed Price · Currency is HKD

0.1200

-0.0010 (-0.83%)

At close: Oct 9, 2026

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Chinese Medicine Business (Excluding Medical and Healthcare Services)	59.26M	29.49M	51.80M	-	107.55M
Medical and Healthcare Services	22.23M	19.05M	13.04M	14.97M	7.35M
Pharmaceuticals and Medical Technologies Business (Excluding Chinese Medical Business)	249.28M	285.71M	471.20M	462.64M	396.50M
Elimination of Intersegment Sales	-7.82M	-4.32M	-3.94M	-5.14M	-1.45M
Chinese Medical Business	-	-	-	74.23M	-
Total	322.95M	329.94M	532.09M	546.69M	509.96M

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Chinese Mainland	315.14M	320.99M	524.13M	538.11M	505.95M
Hong Kong	6.39M	7.74M	6.47M	7.71M	3.64M
Australia	1.42M	1.20M	1.49M	880.00K	366.00K
Total	322.95M	329.94M	532.09M	546.69M	509.96M